CarThera: Clinical Trials

7 trials sponsored by CarThera, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting, 2 completed, 2 recruiting. 5 Phase 1, 5 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 15Completed 2, Recruiting 2, Active not recruiting 1
Phase 25Active not recruiting 2, Completed 2, Recruiting 1
Phase 31Active not recruiting 1

Follow CarThera: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapeutic Approach of Repeated Transient Blood-brain Barrier Opening in Amyotrophic Lateral Sclerosis.
SonoCloud-4 (SC4) device - Amyotrophic Lateral Sclerosis, Charcot Disease
Phase 1 / Phase 2RecruitingAssistance Publique - Hôpitaux de Paris232026-07-152026-08-10
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
SonoCloud-9 (SC9), Carboplatin, Lomustine - Glioblastoma, Recurrent Glioblastoma
Phase 3Active not recruitingCarThera5602024-01-292026-11-05
Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
Balstilimab, Botensilimab, Liposomal Doxorubicin - Newly Diagnosed Glioblastoma, Glioblastoma, Isocitric Dehydrogenase (IDH)-Wildtype
Phase 2Active not recruitingNorthwestern University252024-01-192026-09-29
Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients
SonoCloud® (9 transducers) - Malignant Brain Tumor, Malignant Glioma
Phase 1RecruitingAssistance Publique - Hôpitaux de Paris242023-02-062026-05-06
Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
Sonication for opening of blood-brain barrier, Chemotherapy, albumin-bound paclitaxel, Chemotherapy, carboplatin - Glioblastoma, Gliosarcoma
Phase 1 / Phase 2Active not recruitingNorthwestern University572020-10-292026-10-26
Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9
SonoCloud-9, Carboplatin - Glioblastoma, Adult
Phase 1 / Phase 2CompletedCarThera382019-02-182022-09-07
Blood Brain Barrier Opening in Alzheimer' Disease
SONOCLOUD® - Alzheimer Disease
Phase 1 / Phase 2CompletedAssistance Publique - Hôpitaux de Paris102017-06-262022-04-12

Conditions studied

Glioblastoma (4)  ·  Gliosarcoma (2)  ·  Alzheimer Disease (1)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Brain Neoplasms (1)  ·  Frontotemporal Dementia (1)  ·  Glioma (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neuroinflammatory Diseases (1)  ·  Plaque, Amyloid (1)

Interventions

Carboplatin (3)  ·  Albumin-Bound Paclitaxel (1)  ·  Drug Therapy (1)  ·  Lomustine (1)  ·  Sonication (1)  ·  Temozolomide (1)  ·  balstilimab (1)  ·  liposomal doxorubicin (1)

Countries

France (5)  ·  United States (4)  ·  Austria (1)  ·  Belgium (1)  ·  Denmark (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Roger Stupp, MD (2)  ·  Adam M Sonabend, MD (1)  ·  Adam Sonabend, MD (1)

Results publications

PMID 37142373, PMID 34815790, PMID 35260178, PMID 35552677, PMID 38396134, PMID 39028616, PMID 39724015

NIH funding

2016 (1), 2023 (1)